Illumina Acquires GRAIL to Accelerate Patient Access to Life-Saving Multi-Cancer Early-Detection Test

Sep 7, 2021 SAN DIEGO, Sept. 7, 2021 /PRNewswire/ — Illumina, Inc. (NASDAQ: ILMN) and Merck (known as MSD outside the United States and Canada) today announced a partnership to develop and commercialize tests that identify genetic mutations used in the assessment of homologous recombination deficiency (HRD). Patients whose tumors are HRD-positive may be eligible for... Read more

ENPICOM introduces a powerful liability prediction solution to de-risk antibody development

The IGX Platform empowers researchers to accurately predict exposed liabilities for thousands of sequences at the same time using high-throughput structural modeling Caption:The IGX Platform to select better antibodies. To download image, please click here. ‘s-Hertogenbosch, The Netherlands – September 7, 2021 – Life Science Newswire – ENPICOM, an innovative bioinformatics software company, announced today at the Biologics UK conference new IGX... Read more

Speeding up Breast Cancer Diagnosis in Egypt: GE Healthcare, Gustave Roussy and the Egypt Ministry of Health Partner to Create Rapid Breast Cancer Diagnosis Clinics

Cairo, Egypt and Villejuif & Buc, France – September 7, 2021 – GE Healthcare, Gustave Roussy and the Egypt Ministry of Health (MOH) signed a preliminary agreement leveraging Gustave Roussy’s One Stop Breast Cancer diagnostics program to increase the speed and the accuracy of breast cancer diagnosis in Egypt. Breast cancer is the most common... Read more

Roche to present data from industry leading portfolio at ESMO 2021 showing significant progress in early stage and uncommon cancers

First data to be presented from the phase II coopERA Breast Cancer study evaluating neoadjuvant giredestrant treatment for oestrogen receptor (ER)-positive, HER2-negative breast cancer New data from the phase III IMpower010 study provide further insights into the role of Tecentriq® (atezolizumab) in early-stage non-small cell lung cancer (NSCLC) Genomic data from the phase II CUPISCO... Read more

The Intricate Network of Immune Cells Revealed by Multiplex Tissue Microscopy

When our immune systems identify invaders – such as parasites, bacteria or viruses – it can spark inflammation, which brings fluid and immune cells to the area of infection. While this can be very effective in battling infection, it also has collateral damage on nearby healthy tissues. In our daily lives, just by eating or... Read more

Pacific Biosciences of California, Inc. to Present at Upcoming Investor Conferences

MENLO PARK, Calif., Sept. 03, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB) announced today that its executives will be speaking at the following investor conferences: Wells Fargo Virtual Healthcare Conference on September 10, 2021, Fireside Chat at 12:40 pm Eastern Time (9:40 am Pacific Time) Morgan Stanley 19th Annual Global Healthcare... Read more

Thermo Fisher Scientific Awarded $192.5 Million U.S. Government Contract to Expand Domestic Pipette Tip Manufacturing

Thermo Fisher Scientific Awarded $192.5 Million U.S. Government Contract to Expand Domestic Pipette Tip Manufacturing New capacity will help U.S. customers meet current and future demand surges for vital laboratory plastics WALTHAM, Mass., Sept. 2, 2021 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced a $192.5 million contract... Read more

SCIEX builds on cadence of innovation in biopharma with Biologics Explorer

New application software enables protein characterization analysis for the ZenoTOF 7600 system September 01, 2021 Framingham, MA — SCIEX, a global leader in life science analytical technologies and Danaher operating company, launches Biologics Explorer software, enabling customers to acquire insights from their high-resolution protein characterization data, and reach decisions quickly and confidently on the most important... Read more

SCIEX presents industry first multi-capillary system for CE-SDS, the BioPhase 8800 system

Instrument ushers in a new phase of biologic characterization, empowering scientists to analyze more samples and molecules to meet next-gen drug development challenges September 01, 2021 Framingham, MA — SCIEX, a global leader in life science analytical technologies and Danaher operating company, presents the latest capillary electrophoresis solution, the BioPhase 8800 system. This is the only... Read more